Seppic presents MONTANIDE™ GEL P PR, its first aqueous adjuvant for injectable vaccines dedicated to avian species

Share
  • November 30, 2021
  • 1 min of read time

Seppic presents MONTANIDE™ GEL P PR, its first aqueous adjuvant for injectable vaccines dedicated to avian species

For more than 40 years, Seppic has been supporting its clients’ vaccine development by offering a large range of adjuvants to meet various needs while respecting each species. With MONTANIDE™ GEL P PR, Seppic extends its range and confirms its expertise in this field.

Injectable vaccines dedicated to avian species are usually formulated with oil-based adjuvants allowing to obtain emulsions, especially water-in-oil ones. 
Very effective immunologically speaking, those oily adjuvants can be less tolerated than aqueous adjuvants by sensitive species.

Seppic launches MONTANIDE™ GEL P PR, an aqueous adjuvant  based on a polymeric technology exclusively dedicated to avian injectable vaccines, meeting the need for innocuity in avian market (especially for farm poultry bred for their meat like broilers, ducks, hens).
In addition, MONTANIDE™ GEL P PR is particularly stable and can resist destabilising antigenic media frequently used in avian vaccines. 

Thus, Seppic enriches its MONTANIDE™ range with a stable, efficient and safe adjuvant for effective injectable vaccines adapted to avian species, even the more sensitive ones.